Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For VIVO
Valuation Somewhat Weak
43%
Profitability n.A.
Fin. Growth Balanced
50%
Leverage & Liquidity Weak
17%
Per Share Metrics Bad
0%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q4 Q1 Δ in %
Current Ratio -29.42 2.56 3.63
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA -69.35 1.73 -5.66
Naive Interpretation member
2 Per Share
Metric Q4 Q1 Δ in %
Book Value -7.79 7.76 8.41
Cash -9.33 1.69 1.86
Capex 23.93 -0.06 -0.08
Free Cash Flow -234.65 -0.11 -0.03
Revenue -13.65 1.30 1.50
Naive Interpretation member
3 Profitability
Metric Q4 Q1 Δ in %
Gross Margin 6.97 0.55 0.52
Operating Margin 598.14 -0.49 0.07
ROA 429.97 -0.07 0.01
ROE 464.96 -0.09 0.02
ROIC 383.38 -0.10 0.02
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of VIVO is permitted for members.
5 Growth
The "Growth Entry" for the Focus of VIVO is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of VIVO is permitted for members.